These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17066144)

  • 21. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
    Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
    Crouch PJ; Barnham KJ; Bush AI; White AR
    Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis.
    Marcello E; Epis R; Di Luca M
    Eur J Pharmacol; 2008 May; 585(1):109-18. PubMed ID: 18377893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New type of diabetes linked to Alzheimer's disease. Reduced levels of insulin produced in brain can lead to death of key brain cells.
    Health News; 2005 Jul; 11(7):8-9. PubMed ID: 16050025
    [No Abstract]   [Full Text] [Related]  

  • 25. Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease.
    Blázquez E; Velázquez E; Hurtado-Carneiro V; Ruiz-Albusac JM
    Front Endocrinol (Lausanne); 2014; 5():161. PubMed ID: 25346723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging links between type 2 diabetes and Alzheimer's disease.
    Sridhar GR; Lakshmi G; Nagamani G
    World J Diabetes; 2015 Jun; 6(5):744-51. PubMed ID: 26069723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediabetes and Alzheimer's Disease.
    Bitra VR; Rapaka D; Akula A
    Indian J Pharm Sci; 2015; 77(5):511-4. PubMed ID: 26798163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin Resistance in Alzheimer's Disease.
    Ferreira LSS; Fernandes CS; Vieira MNN; De Felice FG
    Front Neurosci; 2018; 12():830. PubMed ID: 30542257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease.
    Rizvi SM; Shaikh S; Waseem SM; Shakil S; Abuzenadah AM; Biswas D; Tabrez S; Ashraf GM; Kamal MA
    EXCLI J; 2015; 14():684-96. PubMed ID: 27152105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin Resistance, a Risk Factor for Alzheimer's Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach.
    Affuso F; Micillo F; Fazio S
    Biomedicines; 2024 Aug; 12(8):. PubMed ID: 39200352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetes mellitus and the cerebrovascular disease].
    Maruyama M; Takizawa M; Ishida H
    Clin Calcium; 2003 Sep; 13(9):1153-7. PubMed ID: 15775195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated Systems Analysis Deciphers Transcriptome and Glycoproteome Links in Alzheimer's Disease.
    Matsui Y; Togayachi A; Sakamoto K; Angata K; Kadomatsu K; Nishihara S
    bioRxiv; 2024 May; ():. PubMed ID: 38234803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic replacement strategies in Alzheimer's disease: the postsynaptic dilemma. Commentary on Dawson et al. "Pharmacological mechanisms and animal models of cognition".
    Fibiger HC
    Behav Pharmacol; 1992 Aug; 3(4):299-300. PubMed ID: 11224130
    [No Abstract]   [Full Text] [Related]  

  • 34. Type 2 diabetes and Alzheimer's disease: from common pathologies to potential new therapeutics.
    Levy DE
    J Diabetes Sci Technol; 2007 Jul; 1(4):590-4. PubMed ID: 19885123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction.
    Stoeckel LE; Arvanitakis Z; Gandy S; Small D; Kahn CR; Pascual-Leone A; Pawlyk A; Sherwin R; Smith P
    F1000Res; 2016; 5():353. PubMed ID: 27303627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's Disease and Impaired Bone Microarchitecture, Regeneration and Potential Genetic Links.
    Zhang M; Hu S; Sun X
    Life (Basel); 2023 Jan; 13(2):. PubMed ID: 36836731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The bidirectional links between coronavirus disease 2019 and Alzheimer's disease.
    Nouraeinejad A
    Int J Neurosci; 2024 Mar; ():1-9. PubMed ID: 38451045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Your Brain on Insulin: From Heresy to Dogma.
    McNay E
    Perspect Psychol Sci; 2014 Jan; 9(1):88-90. PubMed ID: 26173246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer Symposium. Etiopathogenetic mechanisms of Alzheimer's disease.
    Pepeu G
    IDrugs; 2000 Jul; 3(7):742. PubMed ID: 16080040
    [No Abstract]   [Full Text] [Related]  

  • 40. Alzheimer's disease - the therapeutic era.
    Wolmark Y
    Drug Discov Today; 1999 Apr; 4(4):149-151. PubMed ID: 10322271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.